Rafał Burczyk

Rafał Burczyk

Auto-generated profile, based on publicly available information

Rafał Burczyk

Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2023 in Medycyna Ogólna i Nauki o Zdrowiu
Verified
Journal Article
Open access
JKJakub Kuciński
Jakub Kuciński
ZFZuzanna Fryska
Zuzanna Fryska
AWAdam Wołejko
Adam Wołejko
PSPaweł Semeniuk
Paweł Semeniuk
RBRafał Burczyk
Rafał Burczyk
EMEwelina Mazurek
Ewelina Mazurek
Introduction and objective: Vitamin D is a group of steroidal compounds that play an important role in calcium and phosphate metabolism. It exists in two forms, as ergocalciferol and cholecalciferol. Its deficiency is widespread globally, including Poland, especially during the autumn-winter...

15 February 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
ZFZuzanna Fryska
Zuzanna Fryska
JKJakub Kuciński
Jakub Kuciński
KKKacper Kulik
Kacper Kulik
KMKrystian Matusz
Krystian Matusz
RBRafał Burczyk
Rafał Burczyk
AWAdam Wołejko
Adam Wołejko
INTRODUCTION Depression is a common and serious mood disorder mainly manifested by sadness, anhedonia, lack of hope and interest in activities once enjoyed. According to WHO depression is a leading cause of disability and inability to work worldwide. Chronic disease is every condition lasting more than 1 year and requiring medical attention. The aim of this article is to show challenges of depression and chronic diseases coexistence. DISCUSSION Depression might be a factor causing difficulties in diagnosing chronic diseases as patients are less likely to cooperate. On the other it might lead to worse compliance and higher risk of chronic diseases’ development. Studies show depression coexisting with chronic illnesses is a valid problem for public health and aggravates the course and effects of treatment of those conditions. Treating an underlying disease is as important as treating depression itself as it might lead to reduction in symptoms of depression. Moreover doctors should choose drugs having regard to depression as well as lingering conditions. SUMMARY Depression still seems to be diminished and ignored in patients with chronic illnesses even though it is proved to have a destructive influence on the health of patients. It is of high importance to raise an awareness of doctors on that subject and its scale. There are plenty of treatment methods for depression in case of chronic diseases co-occurence which gives hope for improving a quality of life of patients and achieving better effects of therapy of an underlying disease.

12 November 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KWKarolina Winiarek
Karolina Winiarek
MMMartyna Michalska
Martyna Michalska
WWWiktor Wardyn
Wiktor Wardyn
CGCezary Guzowski
Cezary Guzowski
JGJoanna Anna Guzowska
Joanna Anna Guzowska
KKKornelia Kędziora-Kornatowska
Kornelia Kędziora-Kornatowska
Introduction: Urinary incontinence is a prevalent health issue that profoundly impacts the quality of life for patients worldwide. Traditional treatments, including pharmacotherapy and surgical procedures, often fall short, leaving many individuals struggling with bladder control issues that restrict physical and social activities and cause significant psychological distress. Recent advancements in therapeutic methods—encompassing behavioral therapies, cutting-edge medical technologies, innovative pharmacotherapy, and advanced surgical techniques—offer promising alternatives. By exploring the effectiveness and advantages of these novel approaches, we can enhance treatment accessibility and elevate the quality of care for those affected by urinary incontinence, ultimately improving their daily functioning and overall well-being. Abbreviated description of the state of knowledge:Current research on innovative treatments for urinary incontinence indicates significant advancements in enhancing patients' quality of life. These cutting-edge methods encompass behavioral therapies like pelvic floor muscle training, state-of-the-art medical technologies such as nerve stimulation, new pharmacological treatments with high efficacy and minimal side effects, and advanced surgical interventions, including artificial sphincter implants and urinary tract modifications. Conclusions: Urinary incontinence is a prevalent health issue that significantly deteriorates the quality of life, particularly affecting half of women and one-third of men over the age of 80. As our society ages and the number of individuals affected by this condition rises, understanding and advancing treatment methods become increasingly crucial. Ongoing research aims to discover new and improved therapeutic approaches with minimal side effects, offering hope for enhanced patient outcomes and better management of urinary incontinence in the future.

16 December 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DZDaria Ziemińska
Daria Ziemińska
KMKarina Motolko
Karina Motolko
RBRafał Burczyk
Rafał Burczyk
KDKonrad Duszyński
Konrad Duszyński
ETElżbieta Tokarczyk
Elżbieta Tokarczyk
Introduction and Objective: Corneal transplantation is an increasingly common surgical procedure, with lamellar keratoplasty now favored over penetrating keratoplasty due to its advantages in outcomes and precision. Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "corneal transplantation rejection" and "high risk of rejection," underscores the need for advancements in understanding and managing graft rejection. Brief knowledge status: Key insights highlight the importance of deeper exploration into the immunological mechanisms of rejection to refine therapeutic strategies. The development of bioengineered materials like acellular porcine corneal stroma (APCS) offers a promising solution to the global donor shortage, though further validation of their clinical utility is needed. Complementary therapies such as amniotic membrane transplantation show promise in mitigating graft failure and treating corneal surface disorders due to their anti-inflammatory and regenerative properties. Moreover, comparative studies suggest that advanced keratoplasty techniques, such as Descemet Membrane Endothelial Keratoplasty (DMEK), may achieve lower rejection rates compared to alternatives like Descemet Stripping Automated Endothelial Keratoplasty (DSAEK). Discussion: Future priorities include advancing drug delivery systems, ensuring the feasibility and accessibility of bioengineered materials, and conducting large-scale multicenter trials to validate novel treatments and surgical methods across diverse populations. Summary: Addressing these challenges is particularly crucial for high-risk and pediatric patients, with the ultimate goal of reducing graft failure rates and the necessity for repeat interventions.

12 November 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KWKarolina Winiarek
Karolina Winiarek
MMMartyna Michalska
Martyna Michalska
WWWiktor Wardyn
Wiktor Wardyn
CGCezary Guzowski
Cezary Guzowski
JGJoanna Anna Guzowska
Joanna Anna Guzowska
KKKornelia Kędziora-Kornatowska
Kornelia Kędziora-Kornatowska
Aim: The aim of this article is to review the latest scientific research on the influence of intestinal microbiota on the development of diseases. In this article we will discuss the importance of the intestinal microbiota, the differences in the composition of the microbiota between healthy and sick people and the relationship between the intestinal microbiota and metabolic, inflammatory, cardiovascular and neurodegenerative diseases. Abbreviated description of the state of knowledge: The gut microbiota plays a key role in human health by influencing the development and progression of various diseases. Numerous studies have shown that an imbalance in gut microbiota, called dysbiosis, may be linked to a number of conditions. Intestinal microflora interacts with the immune system, modulates inflammation and influences metabolic pathways, which emphasizes its importance in the development of diseases. Conclusions: Intestinal microflora is crucial to health, regulating immune, metabolic and neurological functions. Dysbiosis, i.e. disturbance of the balance of intestinal microflora, is associated with diseases such as type 2 diabetes, obesity, inflammatory bowel diseases, allergies, autoimmune diseases and neuropsychiatric disorders. Healthy microflora, influenced by diet, pH and nutrients, are essential for metabolism, immune system regulation and neuronal communication. Recently, scientists have become interested in the possibility of using this knowledge in treatment. Appropriate dietary management, probiotic supplementation and fecal microflora transplantation show promising potential. Future research should focus on elucidating the specific mechanisms by which the gut microbiota influences disease processes and developing targeted therapies to exploit the therapeutic potential of the microbiota.

15 November 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MMMartyna Michalska
Martyna Michalska
KWKarolina Winiarek
Karolina Winiarek
WWWiktor Wardyn
Wiktor Wardyn
ETElżbieta Tokarczyk
Elżbieta Tokarczyk
DZDaria Ziemińska
Daria Ziemińska
JGJoanna Anna Guzowska
Joanna Anna Guzowska
Introduction: Colostrum is uniquely rich in immunoglobulins, growth factors, antibacterial peptides, probiotics, prebiotics, and essential vitamins and minerals. Available as a supplement, BC is used to prevent gastrointestinal infections, boost immune support, and aid in managing chronic inflammation, autoimmune diseases, and even athletic recovery. Aim: The aim of this article is to assess the potential benefits of colostrum across various health areas, including gastrointestinal health, immune system support, respiratory diseases, dermatology, autoimmune conditions and the development of preterm infants. The article will also present a critical analysis of current scientific data and examine future research directions and therapeutic advancements. Review methods: This article is based on a comprehensive, non-systematic review of the scientific literature. A thorough search of the PubMed database was conducted, and 45 sources published up to 2024 were analyzed to ensure that the information presented is current and relevant. Abbreviated description of the state of knowledge: Analysis of the literature suggests that colostrum may provide passive protection, reduce inflammation and support gut integrity in preterm infants. Inflammatory bowel disease may benefit from colostrum, though results for IBS are mixed. It aids wound healing, has anti-aging effects, and shows potential in autoimmune disease management. It also boosts respiratory immunity and aids athletes' recovery and performance. Conclusions: Colostrum contains bioactive components like immunoglobulins, lactoferrin, and growth factors. While current studies highlight its benefits in enhancing immunity, supporting gut health, and managing inflammatory conditions, more comprehensive clinical trials are required to confirm its efficacy and safety across various populations and health conditions.